Clinical • P2 data • Circulating tumor DNA • Metastases
|
HER-2 (Human epidermal growth factor receptor 2)
|
HR positive • HER-2 negative • HR positive + HER-2 negative • PTEN mutation + HR positive
|
Ibrance (palbociclib) • fulvestrant • letrozole • Undisclosed CDK4/6 inhibitor